BRK-B vs GRF
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
The deterministic health profile is weak, highlighted by a Piotroski F-Score of 3/9, indicating deteriorating operational efficiency and profitability trends. While the company maintains a fortress balance sheet with a Debt/Equity ratio of 0.19 and a Current Ratio of 7.07, the stock is trading at a significant premium to its growth-based intrinsic value of $217.21. Negative YoY revenue and earnings growth, coupled with a bearish technical trend, offset the positive analyst sentiment and long-term historical performance.
GRF exhibits a stable financial profile with a Piotroski F-Score of 5/9 and a significant valuation discount, trading at $10.10 against a Graham Number of $18.48. While the company offers an attractive dividend yield of 8.42% and a low P/E of 7.95, it is hampered by stagnant earnings growth (0.40%) and slightly negative revenue growth (-2.00%). The stock is currently trading below its book value (P/B 0.84), suggesting deep value, but the 0/100 technical trend indicates a lack of market momentum. Overall, it presents as a classic value play with high income potential but no immediate growth catalyst.
Compare Another Pair
Related Comparisons
BRK-B vs GRF: Head-to-Head Comparison
This page compares Berkshire Hathaway Inc. (BRK-B) and Eagle Capital Growth Fund, Inc. (GRF) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.